ライフサイエンスコーパス: sexually active

1 asm, 4) dry orgasm, and 5) whether they were sexually active.

2 (40.4%) of women and 437 (54.9%) of men were sexually active.

3 heir bodies (P =.004) were more likely to be sexually active.

4 clinics and 23% in the control clinics were sexually active.

5 men aged 15-19 years who had recently become sexually active.

6 e 3-year survivors who defined themselves as sexually active.

7 sted HIV negative in NHBS and were currently sexually active.

8 ften viewed as asexual or incapable of being sexually active.

9 f vaccinating adolescents before they become sexually active.

10 ded women aged 18-39 years who had ever been sexually active.

11 eption for those youth who are or plan to be sexually active.

12 ounseling costs, and whether the patient was sexually active.

13 Many older adults are sexually active.

14 sal or other intimate relationship and to be sexually active.

15 Chlamydia trachomatis screening rate for sexually active 14- to 18-year-old girls during routine

16 Compared to 2003-2006, 4vHPV prevalence in sexually active 14- to 24-year-olds in 2011-2014 decreas

17 Among sexually active 16-24-year-olds, 54.2% (51.4-56.9) of wo

18 HIV-seronegative, sexually active, 18-24-year-old Kenyan men participating

19 Of those who were sexually active, 47% reported no or little desire, 80% r

20 %; P<.001) and among those who had ever been sexually active (82.7%) than among those who had not (63

21 Among respondents who were sexually active, about half of both men and women report

22 hat men and women differed in rates of being sexually active across time (P < .001) and in overall se

23 We, therefore, recommend screening all sexually active adolescent females for chlamydia infecti

24 Although routine screening of all sexually active adolescent females for Chlamydia trachom

25 reased the C trachomatis screening rates for sexually active adolescent girls during routine checkups

26 Although annual C trachomatis screening of sexually active adolescent girls is recommended by healt

27 For this purpose, sexually active adolescent women (n = 345) were recruite

28 he cumulative prevalence of HPV infection in sexually active adolescent women is extremely high, invo

29 continue with regular chlamydia screening in sexually active adolescent women, have a low index of su

30 ification (for C. trachomatis only) from 255 sexually active adolescent women.

31 and is a recommended contraceptive device in sexually active adolescent women.

32 This recommendation applies to all sexually active adolescents and adults, including pregna

33 ends intensive behavioral counseling for all sexually active adolescents and for adults who are at in

34 ary care and related settings, especially in sexually active adolescents and in adults at increased r

35 This recommendation applies to all sexually active adolescents and to adults who are at inc

36 Use of urine assays for screening sexually active adolescents has the potential to signifi

37 Among sexually active adolescents in psychiatric treatment (N=

38 Annual chlamydia screening of sexually active adolescents is an important method for e

39 For most sexually active adolescents, pregnancy is unintended.

40 through exposure as subadults to unrelated, sexually active adult males.

41 mised trial that recruited HIV-1 uninfected, sexually active adults aged 18-35 years from five sites

42 ptomatic cutaneous neoplasms in children and sexually active adults as well as persistent opportunist

43 In the United States, 1 in 5 sexually active adults is infected.

44 Among sexually active adults, new genital HSV-1 infections are

45 is B vaccination provided to adolescents and sexually active adults.

46 A total of 72% of women were sexually active after transplantation.

47 via cohort vaccination of those entering the sexually active age classes, they could have a substanti

48 mbined, (i) the extremely high prevalence in sexually active AGMs, (ii) the very efficient SIV transm

49 Of the 39 individuals enrolled, 28 had been sexually active and all had sexual difficulties.

50 This increased risk occurs in both sexually active and celibate men, suggesting that it ari

51 vid women, UI was associated with ever being sexually active and no COC use, as well as lower psychol

52 est rates reported by students who were ever sexually active and not using COCs (21.5% [CI, 16.7% to

53 health as being poor were less likely to be sexually active and, among respondents who were sexually

54 All sexually active and/or substance-using HIV-infected MSM

55 again at risk of infection when they become sexually active as adolescents.

56 Analyses included 209 women sexually active at baseline (78.6% of total sample).

57 Median time they had been sexually active at diagnosis was 3.2 years (2.6-6.5).

58 (46%) of 385 participants who reported being sexually active at enrolment reported abstinence at thei

59 Among people who were sexually active before and after AMI, women were less li

60 nce an acute myocardial infarction (AMI) are sexually active before the AMI, but little is known abou

61 The 59 participants sexually active before the trial were the main target of

62 s in the past 5 years with increased risk in sexually active black Caribbean (OR 2.74 [95% CI 1.22-6.

63 l, South Africa, who were HIV uninfected and sexually active consented to HIV-1 RNA testing twice a w

64 o HPV-naive women, and women who are already sexually active, could substantially reduce the incidenc

65 Only 1 seroconversion occurred among the 42 sexually active couples (23.7% of the 177 sexually activ

66 In contrast, the incidence in sexually active couples who infrequently used or did not

67 42 sexually active couples (23.7% of the 177 sexually active couples) who always used condoms.

68 ease in mast cells in the medial habenula of sexually active doves compared with controls.

69 Among the 177 couples who remained sexually active during the prospective study period, 20

70 These findings support screening sexually active female adolescents at each visit, even i

71 Screening guidelines recommend testing all sexually active female adolescents for Chlamydia trachom

72 se nonsexual risky behavior and pregnancy in sexually active female adolescents.

73 Among the 2288 sexually active female participants (56.7% white; 33.6%

74 Descriptive analyses were conducted among sexually active female students (n = 2288); logistic reg

75 istic regression analyses were restricted to sexually active female users of LARC and moderately effe

76 gs support current recommendations to screen sexually active females age 25 years or younger for chla

77 Among a cohort of 237 sexually active females aged 14-19 years recruited from

78 Sexually active females aged 14-21 years were randomized

79 loped a method to estimate the proportion of sexually active females aged 15-19 years screened for ch

80 sed, the median state-specific proportion of sexually active females aged 15-19 years screened in 200

81 USPSTF recommends screening for chlamydia in sexually active females aged 24 years or younger and in

82 USPSTF recommends screening for gonorrhea in sexually active females aged 24 years or younger and in

83 At enrollment, 260 (40%) of 650 sexually active females ages 14-19 years had an STD: chl

84 s on-campus significantly increased 101% for sexually active females and significantly decreased 36%

85 rrhea remains insufficient at this time, all sexually active females younger than 25 years and all ol

86 Significantly more of the sexually active gay men assessed via ACASI reported havi

87 targeting health promotion interventions at sexually active girls younger than 16 years and those wi

88 If sexually active, girls in this population often have sex

89 F-FTC prophylaxis prevented HIV infection in sexually active heterosexual adults.

90 Sexually active heterosexual male subjects aged 16-35 ye

91 anced efforts may be warranted to screen all sexually active HIV-infected adults for syphilis, chlamy

92 STD testing significantly increased among sexually active HIV-infected adults receiving medical ca

93 ilis, chlamydia, and gonorrhea testing among sexually active HIV-infected adults receiving medical ca

94 During 2009-2013, the proportion of sexually active HIV-infected adults receiving medical ca

95 -blind trial in three South African sites in sexually-active, HIV-negative women, aged 16 years and o

96 We monitored 2393 sexually active HSV-2-seronegative persons for clinical

97 Current guidelines recommend that all sexually active human immunodeficiency virus (HIV)-infec

98 intain an erection, attain orgasm, and being sexually active in comparison with patients undergoing s

99 are presented for the 858 patients who were sexually active in the year prior to the MI, with attent

100 revalence of six psychiatric syndromes among sexually active individuals in the 1996 National Househo

101 We conducted a longitudinal study of 1139 sexually active, inner-city adolescent women receiving t

102 to use condoms were significantly higher for sexually active male students.

103 female rat will approach and withdraw from a sexually active male, thereby controlling the timing of

104 females and significantly decreased 36% for sexually active males.

105 There were 4,106 sexually active males; 1,227 reported they sired 2,323 p

106 As PHIV(+) youth become sexually active, many engage in behaviors that place the

107 HPV infection is highly prevalent in sexually active men and can be detected by use of a vari

108 Anal swab samples were obtained from sexually active men who have sex with men.

109 Among the 59 sexually active men, follow-up data were obtained on 59

110 Participants aged 18-45 years who were sexually active, monogamous, not pregnant, and not sex w

111 perational costs of HIV-related services for sexually active MSM (defined as having sex with men in t

112 valence of HPV infection is high among young sexually active MSM, with the anal canal being the most

113 Men who were recently sexually active (n = 3323) were stratified on the basis

114 In this study, we used data from 6,654 sexually active nonpregnant women across 4 waves of the

115 We prospectively evaluated 796 sexually active, nonpregnant women from 18 through 40 ye

116 g female oral-contraceptive users than among sexually active nonusers.

117 ies, those with siblings, and those who were sexually active, particularly if they had had numerous s

118 d diseases (STDs) in a greater proportion of sexually active patients has become an accepted protocol

119 In sexually active patients, the incremental cost-effective

120 GSCs produce numerous gametes throughout the sexually active period of adult life.

121 Most sexually active persons will have detectable HPV at leas

122 for HIV prevention should target the general sexually active population and not only serodiscordant c

123 xty-one percent of men and 37% of women were sexually active pre-HCT; the prevalence declined to 51%

124 plants, are used by only a small minority of sexually active teens, despite their endorsement by prof

125 Sexually active U.S. women 15 to 29 years of age.

126 ually active and, among respondents who were sexually active, were more likely to report sexual probl

127 associated but only among women not recently sexually active with male partners.

128 Half (48.7%) of adolescent were sexually active with mean age at sexual debut of 14.6+/-

129 elial lesions are common among women who are sexually active with women and occur among those who hav

130 dies, was investigated in 149 women who were sexually active with women.

131 s multicenter cross-sectional study enrolled sexually active women > or =18 years of age who presente

132 for gonorrhea and chlamydia in asymptomatic, sexually active women (including pregnant women) who are

133 Sexually active women (n = 74) were randomized to one of

134 Sexually active women (n=5,871) in the NCI-sponsored Cos

135 matis infection is currently recommended for sexually active women 15 to 25 years old and for women o

136 4813 sexually active women aged 15-49 years were surveyed to

137 %) and 20.9% (95% CI, 19.3%-22.4%) for other sexually active women and men, respectively.

138 trachomatis and N. gonorrhoeae infections in sexually active women and to prevent their costly and se

139 Reporting by sexually active women and women with a history of infert

140 PSTF) recommended that clinicians screen all sexually active women at increased risk for infection fo

141 concurrently obtained plasma and sera in 710 sexually active women by using a glycoprotein G2-based e

142 A total of 2353 sexually active women for whom cervicovaginal HPV infect

143 We used data on 12,684 sexually active women from a national survey conducted i

144 ive of sexually transmitted infection, among sexually active women in Brazil.

145 A total of 2017 sexually active women in the control arm of an HPV-16/18

146 randomised controlled trial in HIV-negative, sexually active women recruited from clinics and communi

147 r of positive tests divided by the number of sexually active women screened by each sampling method d

148 ection has been strongly recommended for all sexually active women under the age of 26.

149 Vaginal lactobacilli isolated from 215 sexually active women were identified using whole-chromo

150 contraceptive users were compared with other sexually active women who were using either nonhormonal

151 We assessed 2188 HIV-negative sexually active women with 2625 exposure intervals durin

152 2 randomly selected women, 8554 nonpregnant, sexually active women without hysterectomies underwent i

153 prevention of HIV infection in 1959 healthy, sexually active women, 18 to 45 years of age, from seven

154 rvical lesions in a cross-sectional study of sexually active women, aged 18 to 50 years, from the Uni

155 We randomly assigned sexually active women, aged 18 years or older (>/=16 yea

156 sition and clearance were examined among 972 sexually active women, ages 18 to 85 years, recruited fr

157 Among newly sexually active women, consistent condom use by their pa

158 e need for screening programs that cover all sexually active women, even if they were vaccinated.

159 on interventions that target young, healthy, sexually active women.

160 ydia trachomatis infections are common among sexually active women.

161 amined in a longitudinal cohort study of 751 sexually active women.

162 rachomatis infections are common among young sexually active women.

163 roximating catch-up populations that include sexually active women; vaccine n=9319, control=9325).

164 oking practices in WSW, but longer-duration, sexually active WSW partnerships support a stable favora

165 measured in selected brain regions of young sexually active (YAM), young photoregressed (YPM), old r

166 Sexually active young adults in the small college town o

167 The incidence of HPV infection in sexually active young college women is high.

168 An estimated 80% of sexually active young women in the United States use hor

169 Among sexually active young women the incidence of symptomatic

170 We recruited sexually active young women who were starting a new meth

171 Cases were sexually active young women with acute UTI caused by Esc

172 virus (HPV) infection is highly prevalent in sexually active young women.

173 aseline finding from a diverse sample of 298 sexually active, young transgender women aged 16 through

174 Paired observations were available for 5,683 sexually active, young women (median age, 21 years).

175 Thirty-nine of 92 (42%) sexually active youth had HIV RNA >/=5000 copies/mL afte

176 Sixty-two percent (57/92) of sexually active youth reported unprotected SI.